Skip to main content
. 2018 Jul 4;2(2):81–85. doi: 10.1093/jcag/gwy030

Table 1.

Demographic and histological data of responders and nonresponders to CME

All (n=31) Histological Remission (<15 eos/hpf) (n=18) Non-responders
(≥15 eos/hpf) (nv13)
P
Gender (% males) 26 (84%) 16 (89%) 10 (77%) 0.4
Food allergy (%) 10 (32%) 4 (22%) 6 (46%) 0.2
Age (years) 9 (IQR=7,13) 9 (IQR=14,7) 8 (IQR=5,9) 0.2
Age at diagnosis (years) 6 (IQR=3,9) 6 (IQR=3,9) 5 (IQR=3,8) 0.7
Treatment duration (months) 3 (IQR=3,4) 3 (IQR=3,3) 3 (IQR=3,4) 0.3
Pre-tx (eos/hpf) 37 (IQR=28,61) 38 (IQR=26,59) 37 (IQR=28,63) 0.7
Post-tx (eos/hpf) 7.2 (IQR=2,33) 2 (IQR=0,6) 37 (IQR=29,57) < .00001